trial · primary record
Afimetoran
Cutaneous Lupus Erythematosus (CLE)
| Phase | Phase 2, Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 390 |
| Primary completion | 2031-04 |
| Primary endpoint | Percent change from baseline in CLASI-A total score |
| Registry ID | NCT07881120 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:44:31.458Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07881120
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.